According to PhaseBiotech.com, ANX has a strong chance of getting both their new drugs through the FDA, and that they have huge potential in fast growing cancer markets. I bet GSK or SNY reacts before an NDA and buys them. http://www.phasebiotech.com/2010/01/adve...